BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Cystic fibrosis News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
FDA Approves Vertex Pharmaceuticals (MA)'s KALYDECO™ (Ivacaftor) For Use In Eight Additional Mutations That Cause Cystic Fibrosis     2/24/2014   More...
Vertex Pharmaceuticals (MA)'s Cystic Fibrosis Drug Ivacaftor Misses Goal In Late-Stage Study But Helps Some Adults     12/20/2013   More...
AbbVie, Galapagos NV Ink $405 Million Cystic Fibrosis Pact     9/24/2013   More...
Vertex Pharmaceuticals (MA) Shares Rocket as CF Drug Impresses in Phase 3 Study     8/1/2013   More...
Insmed Incorporated Lung Antibiotic Passes Test But Falls Short of Investor Expectations     7/2/2013   More...
These Mutated Cystic Fibrosis Cells are Worth Billions to Vertex Pharmaceuticals (MA)     6/17/2013   More...
Vertex Pharmaceuticals Incorporated Booms on Cystic Fibrosis Combo Drug Study     4/23/2013   More...
FDA Rejects Pharmaxis Ltd Drug Push Bid     3/19/2013   More...
Vertex Pharmaceuticals Incorporated Readies Late-Stage Cystic Fibrosis Drug Studies     2/27/2013   More...
Cystic Fibrosis Drug From Vertex Pharmaceuticals (MA) is Approved by Canadian Regulators     12/3/2012   More...
Pfizer Inc. Signs a $58 Million Agreement With Cystic Fibrosis Foundation Therapeutics, Inc.     11/20/2012   More...
Vertex Pharmaceuticals (MA) Cystic Fibrosis Drug Passes Key Test     10/16/2012   More...
FDA Panel Backs Novartis Pharmaceuticals Corporation's Cystic Fibrosis Drug     9/7/2012   More...
FDA Questions Novartis AG Cystic Fibrosis Drug     9/4/2012   More...
EU Approves Vertex Pharmaceuticals Incorporated's KALYDECO for Cystic Fibrosis     7/27/2012   More...
 Featured Stories
New Drug Target Found for Cystic Fibrosis Lung Disease, BC Children's Hospital Study     11/8/2012   More...
Sea Sponge Chemical Fixes Cystic Fibrosis Defect, McGill University Study     10/29/2012   More...
Differences Seen in Lung Microbes of Cystic Fibrosis Patients, Stanford University Study     10/1/2012   More...
Big Advance Against Cystic Fibrosis: Stem Cell Researchers Create Lung Surface Tissue in a Dish, Massachusetts General Hospital Study     4/6/2012   More...
Student, 16, Invents New Drug Cocktail to Fight Cystic Fibrosis, Wins Canadian Biotech Challenge, National Research Council of Canada laboratories Reveals     5/12/2011   More...
Cystic Fibrosis Patients May Benefit From Combination Therapy Which Provides Hope For Cure Of Dangerous Infections, McMaster University Study     4/25/2011   More...
New Cystic Fibrosis Drug Improves Lung Function, University of Colorado Study     12/22/2010   More...
Novel Drug Aids CF Kids' Lungs, University of Colorado Study     12/20/2010   More...
Drug Corrects CF Genetic Defect, University of Colorado Reveals     11/18/2010   More...
TOBI Reduces Mortality in Patients with Cystic Fibrosis, Pa Lung Infection, Children's Hospital Boston Study     10/22/2010   More...
One Step Closer to a Drug Treatment for Cystic Fibrosis, University of Missouri Professor Says     10/12/2010   More...
Growth Hormone May Benefit Lungs in CF, University of Connecticut/Hartford Hospital Evidence-Based Practice Center Study     10/7/2010   More...
MP-376 Safe and Effective for Treatment of P. Aeruginosa in CF Patients, University of California, San Diego (UCSD) Study Finds     5/17/2010   More...
New Drug May Treat Cystic Fibrosis, Other Diseases Caused By 'Nonsense Mutations', University of Alabama at Birmingham Study     4/27/2010   More...
University of Pennsylvania Study Finds that Antioxidant Found in Vegetables Has Implications for Treating Cystic Fibrosis     11/17/2009   More...
 More News
Xenetic Biosciences Announces Positive Phase 1 Clinical Data For Pulmoxen™ For Treatment Of Cystic Fibrosis     4/7/2014   More...
Proteostasis Therapeutics, Inc. Announces Extension Of Funded Collaboration With Cystic Fibrosis Foundation Therapeutics, Inc. For Novel Therapies Targeting Most Common CF Mutation     3/4/2014   More...
Galapagos NV (GLPG.BR) Receives EU2.9 Million IWT Grant For Cystic Fibrosis Research     1/13/2014   More...
NovaBiotics Ltd Initiates Development Of Orphan Drug In Cystic Fibrosis     12/17/2013   More...
Galapagos NV (GLPG.BR) Selects Pre-Clinical Candidate For Cystic Fibrosis     12/16/2013   More...
Vertex Pharmaceuticals (MA) (VRTX) Announces Recent Progress and Upcoming Milestones in Research and Development Programs for Cystic Fibrosisv     10/17/2013   More...
Galapagos NV (GLPG.BR) Presents Superior Potentiator Series for CF     10/17/2013   More...
Cystic Fibrosis Foundation Therapeutics, Inc. Provides Savara $1.7 Million Award for Development of AeroVanc for MRSA Lung Infection in Cystic Fibrosis Patients     10/17/2013   More...
Flatley Discovery Lab, LLC Nominates Clinical Candidate for Treatment of Cystic Fibrosis     10/11/2013   More...
Constellation Pharmaceuticals and the University of Pittsburgh School of Medicine Receive Cystic Fibrosis Foundation Research Grant     10/10/2013   More...
Mount Sinai Grants Exclusive License to Plexcera Therapeutics to Develop Treatments for Farber Disease and Cystic Fibrosis     9/13/2013   More...
Syreon Corporation Initiates Observational Study in Cystic Fibrosis     8/28/2013   More...
AmpliPhi Biosciences (TGEN) Presents Data on Bacteriophages in the Treatment of Lung Infections in Cystic Fibrosis     8/8/2013   More...
Cornerstone Therapeutics Inc. Initiates PERTZYE® (pancrelipase) Sales and Marketing Efforts for the Treatment of Exocrine Pancreatic Insufficiency in Patients With Cystic Fibrosis     7/30/2013   More...
TGA of Australia Approves Vertex Pharmaceuticals (MA) (VRTX)'s KALYDECO for Cystic Fbrosis     7/10/2013   More...

 

 

//-->